For example, in ovarian cancer, circE2F2 competitively binds to HuR protein, thereby attenuating its contribution to E2F2 mRNA stability, leading to disruption of E2F2 levels and its participating activities such as cell proliferation and migration (42). This evidence concerns the gene ELAVL1 and ovarian cancer.